Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

127.51
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
35.98
Today|||52-Week Range
147.63
+240.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues47.2M50.6M41.1M47.2M
 
 
 
 
 
Depreciation And Amortization10.2M11.9M19.1M15.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses129.9M222.8M318.1M456.6M
 
 
 
 
 
Research And Development113.0M190.2M276.5M382.4M
 
 
 
 
 
Total Operating Expenses140.1M234.8M337.1M471.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-92.9M-184.2M-296.0M-424.6M
 
 
 
 
 
Extraordinary Charge0.00-220.8M0.000.00
 
 
Interest Expense On Debt0.000.000.001.2M
 
 
Other Expenses-47.0K1.8M76.0K7.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-91.9M-400.6M-290.1M-410.1M
 
 
 
 
 
Income Taxes-2.7M-40.2M0.000.00
 
 
 
Net Income-89.2M-360.4M-290.1M-410.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS61.6M74.3M84.0M85.6M
 
 
 
 
 
Shares To Calculate EPS Diluted61.6M74.3M84.0M85.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.45-$4.85-$3.45-$4.79
 
 
 
 
 
EPS Diluted-$1.45-$4.85-$3.45-$4.79